Holen Sie sich die Stockscreener-App
0.8169
4.73%
0.0369
Finanzdaten der Salarius Pharmaceuticals Inc-Aktie (SLRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
82.51%
1.7716
|
0.9707 | 2.5322 | 3.9714 | 5.4207 |
| Operating Income/Loss |
82.51%
-1.7716
|
-0.9707 | -2.5322 | -3.9714 | -5.4207 |
| Income/Loss From Continuing Operations Before Tax |
94.52%
-1.7153
|
-0.8818 | -2.4428 | -3.8773 | -5.3408 |
| Income/Loss From Continuing Operations After Tax |
94.52%
-1.7153
|
-0.8818 | -2.4428 | -3.8773 | -5.3408 |
|
Net Income/Loss
|
94.52%
-1.7153
|
-0.8818 | -2.4428 | -3.8773 | -5.3408 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,747%
4.1946
|
0.2271 | 3.754 | 2.7091 | 2.392 |
| Diluted Average Shares |
1,747%
4.1946
|
0.2271 | 3.754 | 2.7091 | 2.392 |
| Basic Earnings Per Share |
-0.41
|
- | -0.65 | -1.43 | -2.23 |
| Diluted Earnings Per Share |
-0.41
|
- | -0.65 | -1.43 | -2.23 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):